Endometrial cancer begins when the cells of the inner lining of the uterus, known as the endometrium, become malignant. It is the most common type of cancer in the uterus and is divided into different types based on cell histology.
Although the immunotherapy plus chemotherapy did not improve disease-free survival (DFS) in newly diagnosed, high-risk patients with endometrial cancer, the combination therapy did improve DFS for patients...
Researchers sought to determine the reliability of the use of transvaginal ultrasonography triage to diagnose endometrial cancer in patients who are Black and at risk for the disease.
A first-time analysis using the National Inpatient Sample (NIS) database sought to examine the relationship between polycystic ovary syndrome (PCOS) and gynecologic cancers, including endometrial cancer. ...
Surgical site infections are said to account for approximately 20% of all health care associated infections. Are you familiar with common risk factors for these infections after surgery for an abdominal...
Read our Q&A with Megan Clarke, PhD, MHS, about the role of postmenopausal bleeding in the early detection of endometrial cancer. Then take this quiz to see what you've learned!
In this video, Paulina Haight, MD, discusses her team's study, which aimed to determine the association between platinum-free interval and the response to subsequent treatment for patients with recurrent...
In this video, Anna Jo Smith, MD, MPH, MSc, discusses the use of two FDA-approved immunotherapy treatments for endometrial cancer in patients. She talks about health care disparities surrounding the...
Stephanie Blank, MD, answers questions about the session she hosted at The Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women's Cancer titled “The Future is Now: Determining the Fate of...
In this video, Kari E. Hacker, MD, PhD, discusses the results of her team's study examining the rate of HER2-expression among patients with endometrial cancer, as well as the eligibility of these patient...
In this video, Christian Dagher, MD, discusses the results of his team's study comparing the oncologic outcomes associated with treatment of stage II endometrial cancer with minimally invasive surgery vs...
